Feng Zijin, Hou Jinjun, Yu Yang, Wu Wenyong, Deng Yanping, Wang Xia, Zhi Haijuan, Zhang Linlin, Wu Wanying, Guo De-An
College of Traditional Chinese Medicine, China Pharmaceutical University, Nanjing, China.
Shanghai Research Center for Modernization of Traditional Chinese Medicine, National Engineering Laboratory for TCM Standardization Technology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
Front Pharmacol. 2019 Jul 30;10:845. doi: 10.3389/fphar.2019.00845. eCollection 2019.
The sourcing of plants from multiple botanical origins is a common phenomenon in traditional Chinese medicines. Stem with Hooks (UHs) are approved for using five botanical origins in the Chinese Pharmacopoeia (2015 Edition). All five UHs are commonly used for treating hypertension even though the plants have different chromatographic fingerprints based on our previous study. However, their hypotensive effects and metabolic phenotypes have not been fully studied. In the present study, spontaneously hypertensive rats (SHRs) were orally administered five aqueous extracts (4 g crude drug/kg) prepared from the different UHs over a 6-week period. Systolic blood pressure (SBP) was measured every week, and urine was collected after SBP measurement. Untargeted metabonomics was performed using ultra performance liquid chromatography (UPLC) coupled with an LTQ-Orbitrap mass spectrometer. Bidirectional orthogonal projection to latent structures discriminant analysis (O2PLS-DA), Student's test, and correlation analysis were used for pattern recognition and the selection of significant metabolites. A similar and prolonged reduction in SBP was observed in each of the groups given the five different UHs, while the metabolic profiles were perturbed slightly compared with that of SHR. Further analysis has shown that only a few common, different components were observed within the five groups, which showed the similar antihypertensive effect in spite of the distinct metabolic pathways due to their different alkaloid composition. These results help in understanding the mechanisms of the phenomenon "different species, same effect" of UHs.
在传统中药中,来源于多种植物来源的药材是一种常见现象。《中国药典》(2015年版)批准了五种植物来源的钩藤入药。根据我们之前的研究,尽管这五种钩藤植物具有不同的色谱指纹图谱,但它们都常用于治疗高血压。然而,它们的降压作用和代谢表型尚未得到充分研究。在本研究中,将自发性高血压大鼠(SHRs)连续6周口服给予由不同钩藤制备的五种水提取物(4 g生药/kg)。每周测量收缩压(SBP),并在测量SBP后收集尿液。使用超高效液相色谱(UPLC)结合LTQ-Orbitrap质谱仪进行非靶向代谢组学分析。采用双向正交投影到潜在结构判别分析(O2PLS-DA)、Student's检验和相关性分析进行模式识别和显著代谢物的筛选。给予五种不同钩藤的每组大鼠均观察到SBP出现相似且持续的降低,而与SHR相比,代谢谱略有扰动。进一步分析表明,五组中仅观察到少数几种共同的、不同的成分,尽管由于它们不同的生物碱组成导致代谢途径不同,但仍显示出相似的降压效果。这些结果有助于理解钩藤“不同物种,相同功效”这一现象的机制。